Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Kumar, Harish  [Clear All Filters]
Journal Article
Yadav S, Kumar H, Mahajan M, Sahu SKeshari, Singh SKumar, Yadav RKishor. Local auxin biosynthesis promotes shoot patterning and stem cell differentiation in Arabidopsis shoot apex. Development. 2023;150(23).
Shah M, Kumar H, Qiu S, Li H, Harris M, He J, Abraham A, Crossman DK, Paterson A, Welner RS, et al. Low c-Kit expression identifies primitive therapy-resistant CML stem cells. JCI Insight. 2022.
Ghosh TMitra, Mazumder S, Davis J, Yadav J, Akinpelu A, Alnaim A, Kumar H, Waliagha R, Bird AEChurch, Rais-Bahrami S, et al. Metronomic Administration of Topotecan Alone and in Combination with Docetaxel Inhibits Epithelial-mesenchymal Transition in Aggressive Variant Prostate Cancers. Cancer Res Commun. 2023;3(7):1286-1311.
Anderson NR, Sheth V, Li H, Harris MW, Qiu S, Crossman DK, Kumar H, Agarwal P, Nagasawa T, Paterson AJ, et al. Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling. Leukemia. 2022.
Bhattad S, Mohite RS, Singh N, Kotecha U, Jhawar P, Ramprakash S, Commondoor R, Jayaram A, Rayabarapu P, Kumar H, et al. Profile of 208 patients with inborn errors of immunity at a tertiary care center in South India. Clin Exp Med. 2023.
Mahendiratta S, Bansal S, Sarma P, Kumar H, Choudhary G, Kumar S, Prakash A, Sehgal R, Medhi B. Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review. Biomed Pharmacother. 2021;137:111300.